Introduction {#S1}
============

Parasites belonging to *Cryptosporidium* genus have a worldwide distribution causing gastrointestinal infection in humans and animals. The parasite species can be adapted in various animals and therefore *Cryptosporidium* oocysts have been widely distributed in environment. Humans can infect with *Cryptosporidium* through different transmission routes including direct contact with infected persons (person-to-person transmission) or animals (zoonotic transmission), ingestion of contaminated food (foodborne transmission) and water (waterborne transmission) ([@R1]). During the last two decades, molecular biologic tools have been developed to identify and differentiate the parasite at the species/genotype and subtype levels ([@R2]-[@R3]). These molecular tools have been used in epidemiological studies of *Cryptosporidium* in different areas which found that there are several subtypes of *Cryptosporidium* spp. such as human-specific, animal-specific, and zoonotic *C. parvum* subtypes ([@R4]). The molecular technique that has been commonly used to differentiate *Cryptosporidium* species/genotypes in humans, animals and water samples are polymerase chain reaction (PCR) and PCR- restriction fragment length polymorphism (RFLP) of small subunit of rRNA gene ([@R5]-[@R6]). Another molecular diagnostic tools is based on the *Cryptosporidium* oocyst wall protein (COWP)([@R7]). Generally, PCR and PCR-RFLP of these genes amplify DNA of *C. parvum, C. hominis, C. meleagridis*, and species/genotypes closely related to *C. parvum* and are not able to differentiate the parasite at subgenotypes level ([@R1], [@R4], [@R8]-[@R9]). Sequence analysis of the 60-kDa glycoprotein *(GP60)* gene is a popular molecular tool which enables to identify subgenotypes of various *Cryptosporidium* isolates. Until now, at least six allele families for *C. hominis* and eleven allele families for *C. parvum* were recognized ([@R1], [@R10]-[@R12]). Moreover, sequence analysis of the 70 kDa heat shock protein *(HSP70)* is another molecular tool appeared as a good target for subgenotyping of *Cryptosporidium* isolates based on its high level of heterogeneity spread over the entire sequence ([@R13]). Studies on distribution of *Cryptosporidium* spp. demonstrated that *C. parvum* is responsible for more than 90 percent of human cryptosporidiosis in developed countries while *C. hominis* is dominant in developing countries ([@R4], [@R6], [@R8], [@R12], [@R14]-[@R15]). On the other hand, the anthroponotic transmission route of *C. parvum* has been reported in developing countries and the subtype family IIb is responsible for most human *C. parvum* infections in these areas ([@R2], [@R16]-[@R17]). Also, other anthroponotic subtype families (IIc, IIe) have reported in humans in some regions such as Kenya, and Uganda ([@R17]-[@R19]). However, there are few studies have compared *Cryptosporidium* isolates from different geographical regions using multilocus genotypes tools. Also, there are few reports on the molecular analysis of the various *Cryptosporidium* species in diarrheic or non diarrheic individuals based on several molecular biological tools in Iran and some other developing countries such as Malawi, Nigeria, and Vietnam.

The study aimed to find the diversity and genetic structure of *Cryptosporidium* species in specimens from children and adult living in the United Kingdom, Iran, Malawi, Nigeria, and Vietnam using a combination of established genetic markers.

Materials and Methods {#S2}
=====================

Cryptosporidium isolates {#S2a}
------------------------

Overall, 106 human fecal samples were collected from Iran ([@R21]), Malawi ([@R2]), Nigeria ([@R1]), UK(80) and Vietnam ([@R2]). These samples were positive for *Cryptosporidium* species by either microscopy or ELISA.

Extraction and purification of parasite DNA {#S2b}
-------------------------------------------

DNA was extracted from all specimens using the QIAamp® DNA stool mini kit (QIAGEN Ltd, Crawley, West Sussex, UK). The DNA was further purified according to the kit instructions and stored at -20°C until it was used for PCR assays ([@R5], [@R20]).

18S rRNA gene PCR {#S2c}
-----------------

The existence of the *Cryptosporidium* DNA in fecal sample was verified by amplification of the 18S rRNA gene fragment. The method was performed as previously described ([@R5]). Twenty-six isolates; from Iran (21 samples), Malawi (2 samples), Nigeria (1 sample) and Vietnam (2 samples) were evaluated by the 18S rRNA gene fragment in our previous work ([@R20]).

COWP gene PCR {#S2d}
-------------

All DNA extracts positive at 18S rRNA gene *locus* were further investigated by amplification of the COWP gene fragment using an established method ([@R7]).

GP60 gene PCR {#S2e}
-------------

A nested protocol was carried out with primers amplifying a 480 bp region of the gene spanning the hypervariable polyserine tract. The primers and conditions were according with a protocols previously described ([@R21]).

HSP70 gene PCR {#S2f}
--------------

A nested protocol was utilized with primers amplifying a 1200 bp in the last half of the *HSP70* gene of *Cryproporidium* species. Primers and conditions were carried out according with a method described ([@R13]).

All reactions were performed in a Biometra thermocycler in a Techne Thermal cycler (Techne Ltd, Cambridge, UK). Positive and negative controls were included in every PCR reaction. PCR products were analyzed in 2% agarose gel stained with ethidium bromide.

RFLP analysis of the 18S rRNA and COWP gene fragments {#S2g}
-----------------------------------------------------

RFLP analyses of the 18S rRNA gene fragments were performed using *Ssp*I and *Vsp*I (Roche, Germany) restriction enzymes for species identification and genotyping of *Cryptosporidium* species ([@R5], [@R20]). RFLP analysis of the COWP gene fragment was carried out by *Rsa*I endonuclease (Roche Germany). The restriction digestion was performed at 37°C for 4 hours and a reaction mixture according to the manufacturer's instruction. The digestion products were analyzed in a 2% and 3.2% agarose gel stained with ethidium bromide for 18S rRNA and COWP gene fragments, respectively. Isolates were assembled according to their RFLP patterns, and a representative of each group was selected for sequence analysis.

Sequencing study {#S2h}
----------------

The representative PCR products of the 18S rRNA, COWP, GP60 and HSP70 genes were sequenced. The amplicons were expunged from the agarose gel and purified using MicroSpin Columns Kit according to the manufacturer's instruction (Amersham Biosciences, Buckinghamshire, UK). The purified PCR products were directly sequenced. The ChromasPro programme version1.3 (2003, Technelysium Pty. Ltd, Australia) was used to read all the nucleotide sequences. To edit the consensus sus sequences and multiple alignments of the DNA sequences, a nucleotide editor program (DNASTAR version 5.06, 2003) was used. Nucleotide sequences gained from various *Cryptosporidium* isolates were aligned with published sequences from GenBank by using National Center for Biotechnology Information (NCBI-BLAST program) ([http://blast.ncbi.nlm-.nih.gov/Blast.cgi](http://blast.ncbi.nlm-.nih.gov/blast.cgi)).

The phylogeny of the HSP70 and GP60 genes {#S2i}
-----------------------------------------

The phylogenetic relationships between the HSP70 and GP60 sequences of the *Cryptosporidium* isolates were assessed with NJ-tree method using the phylogenetic analysis software Phylogeny.fr ([@R22]). The tree was anchored by using *C. meleagridis* as the out-group as this species showed less similarity to the other species.

Nucleotide sequence accession numbers {#S2j}
-------------------------------------

The twenty-four sequences were used in this study have been deposited in the GenBank database under the accession no DQ010952-55 and, KF555637-39 for 18S rRNA; JX568159, JX547011 and KF555640-41for COWP; KF577770-75 and JX568160 for GP60; and JX568161-3, KF577767-9 for HSP70 genes.

Ethical Considerations {#S2k}
----------------------

The samples were from Alder Hey Hospital and Liverpool School of Tropical Medicine (LSTM), Liverpool, UK as part of routine diagnosis. The samples obtained from Iran, Malawi, Nigeria and Vietnam all taken as part of studies to investigate the etiology of diarrhoea. Full ethical approval was obtained from the respective National Research Ethical Committees, University of Liverpool, Liverpool, UK.

Results {#S3}
=======

PCR-RFLP and sequencing of the 18S rRNA gene {#S3a}
--------------------------------------------

The 18S rRNA gene fragment was amplified in 76 out of 106 (71.7%) positive samples. *Ssp*I and also *Vsp*I restriction sites characteristic were observed for *C. hominis*, *C. parvum* and *C. meleagridis* in 46, 28 and 1 DNA samples tested, respectively. Among the UK samples, 41(66.1%) *C. hominis* and 21(33.9%) *C. parvum* infections and 1 mixed infection were identified ([Figure1](#F1){ref-type="fig"}). Partial sequences from the 18S rRNA gene were obtained from the UK isolates of *C. hominis* (14 isolates), *C. parvum* (8 isolates) and one mixed *C. hominis/C. parvum* revealed that the *C. hominis* isolates were divers in terms of the size of the T-repeat. Most isolates were 11T but a repeat of 10T and 8T were also observed. These had 99-100% homology to published sequence of *C. hominis* (accession numbers AF159110, EU331242, AJ849464 and AY204240) in GenBank. Each of the *C. parvum* isolates showed 99-100% identity to the published sequence (accession number AY204238). The mixed *C. hominis / C. parvum* specimen showed 99% similarity to either the published strains of *C. hominis* B5b and UG502 (accession numbers AY204240 and AF481962) or the HMa strain of *C. parvum* (accession number AY204238). The results obtained from PCR-RFLP of 18S rRNA gene and sequencing of the isolates from other countries was published elsewhere ([Table 1](#T1){ref-type="table"}).

PCR and sequencing of the COWP gene {#S3b}
-----------------------------------

The successful amplification of *Cryptosporidium* spp. was observed for 49 out of 76 DNA samples. Forty-five isolates were from the UK and four isolates were from Iranian collections. 30 out of 45 (66.6%) *C. hominis* and 14/45 (31%) *C. parvum* were detected among the UK samples. Three out of four (75%) *C. parvum* and one *C. meleagridis* species were identified by this gene in Iranian samples. Amplification of the COWP gene was failed for isolates collected from other countries. *Rsa*I restriction sites characteristic were illustrated bands pattern 106,129 and 284 bp for *C. hominis,* 106 and 413 bp for *C. parvum;* 147 and 327 bp for *C. meleagridis*. Unusual restriction band patterns were observed for the mixed sample identified by PCR-RFLP of 18S rRNA gene (data are not shown). Partial sequences from the COWP gene were obtained from *C*. *hominis* (14 isolates), *C. parvum* (9 isolates) and one from *C. meleagridis*. These identities were confirmed by BLAST search (NCBI).

The identities of *C. hominis*, *C. parvum* and *C. meleagridis* sequences showed 100% similarity to the published strains of 181, 6 and TU1867, respectively, (accession numbers AF266265, KC917325 and AY166840). The mixed *C. hominis / C. parvum* isolate showed 100% homology to the published strain 181 of *C. hominis* (accession number AF266265).

PCR and sequencing of the GP60 gene {#S3c}
-----------------------------------

Among 76 samples positive for the 18S rRNA gene, 51 (67.1%) isolates yielded a PCR product for the GP60 *locus*. Overall, six allele families including Ib, Ib3, Id, IIa, IIc and IId were identified by sequence analysis of the *GP60* gene (fourteen *C. hominis* and nine *C. parvum*). Among the *C. hominis* isolates, twelve isolates with allele group Ib showed 100% sequence identity to a published strain with accession number of JF727788. One isolate with allele group Ib3 and one with Id had 100% and 99% similarity to the published strains of LFY-6 and A16 (accession numbers FJ707314 and AY382670), respectively. Among the *C. parvum* isolates, four isolates with allele group IIa showed 99-100% sequence identity to the published strains (accession number EU200442, EF576978 and GU214364). Two isolates with allele group IIc and three isolates with allele group IId had 98% and 99% similarity to the reported strains (accession numbers GU971627, AB560743 and AB560746); respectively, ([Table 1](#T1){ref-type="table"}). In addition to divers subtypes present in this study, report of *C.parvum* IIaA19G1R1, *C.parvum* IIaA18G1R1, *C.parvum* IIaA22G3R1 and *C.hominis* IdA20 were first record in the UK and Malawian isolates, respectively, ([Table 1](#T1){ref-type="table"}). Of 20 UK isolates, allele group Ib (12 isoleates) and Ib3 (one isolate) of *C. hominis* were found. The remainder were *C. parvum* IIa (4 isolates), IIc (2 isolates) and IId (one isolate). Two isolates from Iran were genotyped as *C. parvum* IId family and one isolate from Malawi classified as *C. hominis* Id allele group. The allele families, *C. parvum* IIb and *C. hominis* Ia, Ie and If were not found in the present study. Except for the negative PCRs, the majority of isolates showed *GP60* alleles concordant with the 18S rRNA and COWP gene results. The mixed infection exhibited the *C. hominis* Ib allele group with 100% similarity to a published strain with accession number of JF727788. Phylogenetic analysis of the *GP60* gene using of the NJ-tree method showed that *C. hominis* and *C. parvum* isolates formed five different clades ([Fig 2](#F2){ref-type="fig"}). The phylogenetic position of all *C. hominis* GP60 subgenotypes was consistent with their preliminary classification, e.g. all subgenotype Ib isolates from the current study grouped with two published Ib sequences (accession numbers FJ707314 and JF727788).

For *C. parvum,* the UK subgenotype IId isolate grouped with two Iranian subgenotype IId isolates and two published IId sequences (accession numbers AB560743 and AB560746) forming monophyletic clades with maximum nodal support (pp=1.00).

PCR and sequencing of the HSP70 gene {#S3d}
------------------------------------

Fifty nine out of 76 (77.6%) samples were successfully amplified by the *HSP70* gene. Partial sequences of the *HSP70* gene were carried out for thirteen *C*. *hominis* (12 isolates from UK and one from Iran), ten *C. parvum* and one *C. meleagridis.* The *HSP70* gene sequences had identities between 99%-100% to the published strain 11 bovine with accession number KC823128 for *C. parvum* and 100% to the published strain 672 with accession number AF329189 for *C. meleagridis*. The identities of *C. hominis* isolates sequences had 99-100% similarity with the published strains of H83, A5, H180 and 497 (accession numbers AF401506, AY380458, AF401504 and AF221535). Direct sequencing of the PCR product from mixed isolate showed 100% homology to the recorded *C. hominis* with accession number AF401506.The sequence result of the isolate obtained from Malawi was in contrast with PCR-RFLP and 18S rRNA sequence, and the sequence of GP60 which all identified it as a *C. hominis* isolate ([Table 1](#T1){ref-type="table"}).

Phylogenetic tree showed a clade contains *C. parvum* and *C. hominis*. All of the *C. parvum* isolates from the UK and Malawi clustered together with a high bootstrap value of 74%. The bootstrap value was 91% for the *C. parvum* isolated from Iran with isolates from the UK and Malawi. Three types of *C. hominis* were identified by sequences and phylogenetic tree of the *HSP70* gene. All of the *C. hominis* isolates from the UK and Iran clustered together with bootstrap value of 84%.Within this group, there are number of sister groups which have statistical support including the UK isolates (AH1 and AH4) with ALR from Iran. The isolate was shown to be a mixed infection of *C. hominis / C. parvum* by 18S rRNA gene was identified solely as *C. hominis* isolate by sequence analysis of *HSP70* gene.

Furthermore, the Malawian isolate was shown to be *C. hominis* by 18S rRNA PCR-RFLP and its DNA sequencing; but was identified as *C. parvum* by sequence analysis of *HSP70* gene ([Fig 3](#F3){ref-type="fig"}).

Discussion {#S4}
==========

Of 106 positive samples, 76 and 49 isolates were amplified by the 18S rRNA and COWP genes. This could be resulted from low DNA concentration, DNA degradation and presence of PCR inhibitors in fecal samples ([@R23]). However, good correlation between species identification was achieved by PCR-RFLP of the COWP, 18S rRNA genes and their sequences demonstrating that the PCR-RFLP of 18S rRNA and COWP gene present a helpful screening tool for species identification ([@R6],[@R7]).

Results obtained from PCR-RFLP and sequencing of the 18S rRNA and COWP genes demonstrated that *C. hominis* is responsible for majority cases of human cryptosporidiosis in the UK and therefore anthroponotic transmission could play a major role in the epidemiology of the disease in the UK. This is in agreement with observations made in the England and Wales ([@R24]) and in contrast with findings obtained from other studies in the UK or other developed countries which indicating *C. parvum* are responsible for more infections than *C. hominis* ([@R4], [@R11], [@R25]-[@R26]).

Results obtained from PCR and sequencing of the *GP60* gene showed the presence of six subgenotypes among the studied isolates (three *C. hominis* and three C. *parvum*). 85.7% of subgenotyped *C. hominis* isolates belong to allele family Ib which were from the UK. The proportion of *C. hominis* subgenotypes Ib3 and Id were 7.1% which found in the UK and Malawian isolates, respectively. These results are in agreement with results obtained from many studies indicating several subgenotypes present in the parasite species and Ib is predominant allele family ([@R10]-[@R11], [@R27]). The presence of allele group Ib *C. hominis* suggested that human to human or water and food-human transmission of cryptosporidiosis had taken place in the children of Liverpool, UK. Among C. *parvum* subgenotypes, IIa allele family was the most common (44.4%) fallowed by IId (33.3%). All three C. *parvum* subgenotypes were found in the UK isolates and IIa was the most prevalent subgenotype (60%). Furthermore, two isolates from the UK were allele group IIc indicating that human-human transmission of *C. parvum* occurs in the UK. This finding is similar with another report from the UK ([@R27]) and other studies performed in different countries ([@R17], [@R28]-[@R29]). IId is another less common *C. parvum* subgenotype which may be responsible for some zoonotic([@R4]) or anthroponotic infections ([@R28]) that were identified in one sample of the UK and two Iranian isolates. These findings are in agreement with a study from Iran that indicating 41.2% of the *C. parvum* infections are caused by IId subtype ([@R30]) or other study in Kuwait ([@R27]). But it is in contrast with other studies finding that IId subtypes of *C. parvum* have never been found in calves or humans in the UK, United States, Canada and Australia ([@R4],[@R27]).

In the current study, three *Cryptosporidium* species were detected by PCR and sequencing of the *HSP70* gene. *C. hominis* subtype A was identified as the main type which is similar to the study of Sulaiman et al. (2001)([@R13]) but this is in contrast with another study that found a limited number of this subtype in Malawi ([@R18]). All of our *C. parvum* isolates were similar to those studied by Sulaiman et al. ([@R31]) and the *C. meleagridis* isolate (genotype 3) was comparable to this parasite type in an adult HIV patient from Kenya ([@R32]). Concordant subtyping results were found at the 18S rRNA, *HSP70* and *GP60* genes for the majority of isolates. Among *C. hominis* isolates, type A and G variants of the *HSP70* gene, all had *GP60* subtype of Ib and 18S rRNA subtype of 11T. Only one isolate showed subtype Ib3 which was subtype C of *HSP70*. Interestingly, one isolate from Iran was similar to published isolate 497 which is different from *C. hominis* types A, C and G of *HSP70* gene. It had been identified as type 11T of *C. hominis* of 18S rRNA (this isolate did not amplify by *GP60* PCR). Furthermore, an isolate from Malawi was detected as *C. hominis* Id by GP60, 18S rRNA PCR-RFLP and sequences, but identified as *C. parvum* by the *HSP 70* sequences. In spite of 18S rRNA and *GP60* results, this isolates is more related to the *C. parvum* IId than the rest of the subgenotype *C. hominis* Ib ([Fig 2](#F2){ref-type="fig"} &[3](#F3){ref-type="fig"}). These findings are similar to results of some other multi-locus studies demonstrating *C. hominis* Ib subgenotype is more related to the *C. parvum* allele groups ([@R13], [@R15]). There are some evidences that phylogenetic analysis of the *GP60* sequences could not separate *C. hominis* and *C. parvum* into distinct branches because some *C. parvum* alleles clustered with *C. hominis* alleles ([@R15]).

The present study identified the mixed infection of *C. hominis* and *C. parvum* in one isolate from a child from Liverpool, UK. There are a few mixed infection reports through the world. The primary identification of the present mixed infection was genotyped based on the PCR-RFLP of 18S rRNA and sequencing and PCR-RFLP of COWP genes. Direct sequencing of the *HSP70* and sequence analysis of cloned COWP and gp15/45/60 genes showed that this isolate belongs to the *C. hominis* and *C. hominis* Ib allele groups ([Table 1](#T1){ref-type="table"}). Furthermore, comparison of direct sequencing of the HSP70 gene and the 18S rRNA gene of this isolate showed that HSP70 gene sequences give better resolution than those based on the 18S rRNA gene (with significantly higher bootstrap values). The possible explanation is that mutations in the *HSP70* gene are spread over the entire sequence while mutations in the 18S rRNA gene occur in a restricted region of the gene. Also, the alignment of sequences is much easier in the HSP70 gene due to limited deletions and insertions ([@R31]).

Conclusion {#S5}
==========

The current study demonstrated the complex subtypes of *C. hominis* isolates present in the studied isolates based on GP60 and HSP70 genes. Application of these genes is suitable in resolving the nature of population structure in a distinct area. Furthermore, this study confirms that human to human and water/food-human transmission of cryptosporidiosis occur in the studied countries. Besides, anthroponotic transmission of *C. parvum* takes place in the UK. This is the first report of *C. parvum* IId subgenotype and three new subtypes of *C. parvum* IIa in the UK and the first multilocus study of three species of *Cryptosporidium* in human from Iran. The importance of the diverse multilocus subtypes demonstrated here on phenotypic and temporal factors or clinical manifestations of the disease should be further investigate.
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![The RFLP for 18S rRNA gene using *Vsp*I digestion enzyme. The bands for *C. hominis* (lanes3-5, 7, 9 and 11) and *C. parvum* (lanes 2, 6 and 10). Lane 8 (Liv.57) has pattern expected for mixed infection of *C. hominis* and *C. parvum*. Line 1, 12 and 13 are molecular marker, positive (*C. parvum*) and negative controls, respectively](IJPA-9-79f1){#F1}

![Phylogeny of *Cryptosporidium* isolates by a rooted NJ-tree based on GP60 gene. The numbers on branches are bootstrap values and the scale bar indicates an evolutionary distance of 0.08 nucleotides per position in the sequence. The reference sequences accession numbers are inserted. N.B. Liv. G1 and G2 are two cloned isolates of the mixed isolate Liv.57](IJPA-9-79f2){#F2}

![Phylogeny of *Cryptosporidium* isolates by a rooted NJ-tree based on *HSP70* gene. The numbers on branches are bootstrap values and the scale bar indicates an evolutionary distance of 0.03 nucleotides per position in the sequence. The reference sequences accession numbers are inserted](IJPA-9-79f3){#F3}

###### 

Distribution of *Cryptosporidium* genotypes and subtypes in isolates from children isolated from Iran, the United Kingdom, Malawi, Nigeria and Vietnam

  No. of isolates                               Source    Species            18S rRNA           COWP                               HSP70              GP60                               Subtype   Accession No.   Identity%
  --------------------------------------------- --------- ------------------ ------------------ ---------------------------------- ------------------ ---------------------------------- --------- --------------- -----------
  12                                            UK        *C. hominis*       *C. hominis*       *C. hominis*                       *C. hominis*       *C. hominis*Ib                     IbA12G2   JF727788        100
  1                                             UK        *C. hominis*       *C. hominis*       *C. hominis*                       *C. hominis*       *C. hominis*Ib3                    IbA16G2   FJ707314        100
  1                                             UK        *C. parvum*        *C. parvum*        *C. parvum*                        *C. parvum*        *C. parvum*IIa                     A19G1R1   EU200442        100
  2                                             UK        *C. parvum*        *C. parvum*        *C. parvum*                        *C. parvum*        *C. parvum*IIa                     A18G1R1   EF576978        100
  1                                             UK        *C. hominis*       *C. hominis*       *C. hominis*                       Neg.PCR            Neg.PCR                            \-        \-              100
  1                                             UK        *C. parvum*        *C. parvum*        *C. parvum*                        *C. parvum*        *C. parvum*IIa                     A22G3R1   GU214364        99
  1                                             UK        *C. parvum*        *C. parvum*        Neg.PCR                            Neg.PCR            Neg.PCR                            \-        \-              100
  2                                             UK        *C. parvum*        *C. parvum*        *C.parvum*                         *C. parvum*        *C. parvum*IIc                     A5G3      GU971627        98
  1                                             UK        *C. parvum*        *C. parvum*        *C. parvum*                        *C. parvum*        *C. parvum*IId                     A18G1     AB560743        99
  2                                             Iran      *C. parvum*        *C. parvum*        *C.parvum*                         *C. parvum*        *C. parvum*IId                     A21G1     AB560746        99
  1                                             Iran      *C. meleagridis*   *C. meleagridis*   *C. meleagridis*                   *C. meleagridis*   Neg.PCR                            *-*       *-*             100
  1                                             Iran      *C. hominis*       *C. hominis*       Neg.PCR                            Neg.PCR            Neg.PCR                            \-        \-              100
  1                                             Iran      *C. hominis*       *C. hominis*       Neg.PCR                            *C. hominis*       Neg.PCR                            \-        *-*             100
  1                                             Vietnam   *C. hominis*       *C. hominis*       Neg.PCR                            Neg.PCR            Neg.PCR                            \-        \-              100
  1                                             Malawi    *C. hominis*       *C. hominis*       Neg.PCR                            *C. parvum*        *C. hominis* Id                    A20       EF576980        100
  1                                             Nigeria   *C. hominis*       *C. hominis*       Neg.PCR                            Neg.PCR            Neg.PCR                            \-        \-              100
  [\*](#TFN1){ref-type="table-fn"}Mixed=Liv57   UK        *C. hominis?*      *C.h/p*            [\*](#TFN1){ref-type="table-fn"}   *C. hominis*       [\*](#TFN1){ref-type="table-fn"}                             100
  Liv57-2                                       UK                           *C. hominis*                                                                                                                          100
  Liv57-4                                       UK                           *C. parvum*                                                                                                                           100
  Liv57C1&2                                     UK                                              *C. hominis*                                                                                                       100
  LivG1&2                                       UK                                                                                 \-                 *C. hominis*Ib                     IbA12G2   JF727788        100

Represent mixed isolate (Liv.57). This isolate was cloned by pGEM-T essay cloning Kit (Promega, Madison, USA). Liv.57-2 and 4 are two colonies recovered for 18S rRNA gene, Liv.57C1&2 are two colonies recovered for COWP gene and Liv57G1&2 are two colonies recovered for gp15/45/60.

**N.B.**The number of isolates and associated accession number are on base of GP60 sequences. Also, the content of species column is based on the PCR-RFLP of the 18S rRNA gene.
